Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A<sub>1</sub> receptor ligandsJillian G. Baker, Stephen J. Hill, Richard J. Middleton et al.|British Journal of Pharmacology|2010Cited by 94
New Fluorescent Adenosine A<sub>1</sub>-Receptor Agonists That Allow Quantification of Ligand−Receptor Interactions in Microdomains of Single Living CellsRichard J. Middleton, Barrie Kellam, Stephen J. Hill et al.|Journal of Medicinal Chemistry|2007Cited by 86
Synthesis and Characterization of High-Affinity 4,4-Difluoro-4-bora-3a,4a-diaza-<i>s</i>-indacene-Labeled Fluorescent Ligands for Human β-AdrenoceptorsJillian G. Baker, Barrie Kellam, Luke A. Adams et al.|Journal of Medicinal Chemistry|2011Cited by 44
Synthesis and in Vitro and in Vivo Characterization of Highly β<sub>1</sub>-Selective β-Adrenoceptor Partial AgonistsShailesh N. Mistry, Barrie Kellam, Jillian G. Baker et al.|Journal of Medicinal Chemistry|2013Cited by 24
Novel selective β <sub>1</sub> ‐adrenoceptor antagonists for concomitant cardiovascular and respiratory diseaseJillian G. Baker, Peter M. Fischer, Sheila M. Gardiner et al.|The FASEB Journal|2017Cited by 20